Skip to main content

Reviewing Vaccine Pipeline Breakthroughs and Barriers

Monday, February 26, 2024
Majestic Complex
Attend this session to learn about recent research from the BIO Industry Analysis team on the history and future of vaccine pipelines. A dynamic conversation on how to finance this space along with the emergence of platform technologies, mRNA, and monoclonal antibodies will discuss how to continue the advancement through the clinic and to get vaccines to populations around the world.
Phyllis Arthur, Senior Vice President, Infectious Disease & Emerging Science Policy - Biotechnology Innovation Organization (BIO)
Andrew Allen, Co-founder, President and Chief Executive Officer - Gritstone
David Thomas, Senior Vice President, Industry Research - Biotechnology Innovation Organization (BIO)
Rajeev Venkayya, CEO - Aerium Therapeutics
James Wassil, COO - Vaxcyte

Double Helix


Supporting Bank Sponsor


Premier Sponsors

Conference Sponsors


Media Partner


Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.